Acorda Therapeutics | ACOR - Zapasy



Zapasy Zmiana Data
Acadia Pharmaceuticals USD 31.57M 3.1M 2026-03
Agios Pharmaceuticals USD 35.09M 2.17M 2026-03
ALKERMES USD 336.7M 140.08M 2026-03
Amgen USD 6.19B 39M 2026-03
Anika Therapeutics USD 22.84M 4.05M 2026-03
Arrowhead Research USD -173.08M 173.08M 2024-12
Biogen USD 1.95B 219.1M 2026-03
BioMarin Pharmaceutical USD 1.27B 25.66M 2026-03
Cara Therapeutics USD 900K 0 2025-03
Cipla INR 61.6B 5.18B 2025-09
Clal Biotechnology ILS 4.44M 0 2021-03
CSL USD 6.47B 327M 2025-06
Gilead Sciences USD 1.91B 140M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
Grifols EUR 3.56B 63.19M 2024-12
Halozyme Therapeutics USD 155.47M 21.01M 2026-03
Heron Therapeutics USD 54.57M 2.33M 2022-12
Insmed USD 132.91M 841K 2026-03
Ligand Pharmaceuticals USD 13.27M 4.14M 2026-03
MannKind USD 49.17M 13.85M 2026-03
Merck EUR 4.56B 52M 2025-12
Moderna USD 146M 7M 2026-03
Neurocrine Biosciences USD 64.5M 4.5M 2026-03
Novartis USD 6.29B 17M 2026-03
Pfizer USD 10.67B 13M 2026-03
Sanofi EUR 22.69B 1.81B 2025-12
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12
Ultragenyx Pharmaceutical USD 55M 3M 2026-03
Vertex Pharmaceuticals USD 1.77B 79.9M 2026-03